National Investment Services Inc. WI trimmed its stake in Danaher Co. (NYSE:DHR) by 6.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 30,113 shares of the conglomerate’s stock after selling 2,238 shares during the quarter. Danaher makes up 2.7% of National Investment Services Inc. WI’s portfolio, making the stock its 8th biggest holding. National Investment Services Inc. WI’s holdings in Danaher were worth $2,795,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. GQG Partners LLC acquired a new position in shares of Danaher in the second quarter worth $101,000. Zions Bancorporation raised its holdings in shares of Danaher by 118.3% in the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after acquiring an additional 667 shares during the last quarter. Monetary Management Group Inc. raised its holdings in shares of Danaher by 10.7% in the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after acquiring an additional 150 shares during the last quarter. Acrospire Investment Management LLC raised its holdings in shares of Danaher by 185.5% in the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after acquiring an additional 1,100 shares during the last quarter. Finally, Motco raised its holdings in shares of Danaher by 8.8% in the second quarter. Motco now owns 2,011 shares of the conglomerate’s stock worth $170,000 after acquiring an additional 163 shares during the last quarter. 76.05% of the stock is owned by institutional investors.
A number of equities analysts have recently weighed in on DHR shares. Credit Suisse Group reissued a “hold” rating and issued a $99.00 price target on shares of Danaher in a report on Tuesday, December 19th. Zacks Investment Research raised Danaher from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a report on Thursday, October 5th. Morgan Stanley reiterated an “overweight” rating and issued a $95.00 target price (up from $86.00) on shares of Danaher in a research note on Friday, October 6th. Robert W. Baird reiterated a “buy” rating and issued a $99.00 target price on shares of Danaher in a research note on Friday, December 15th. Finally, Cowen reiterated a “buy” rating and issued a $90.00 target price on shares of Danaher in a research note on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $94.91.
Danaher Co. (DHR) traded down $0.37 during trading on Thursday, reaching $98.24. The company had a trading volume of 2,465,200 shares, compared to its average volume of 2,676,600. The firm has a market capitalization of $68,520.00, a price-to-earnings ratio of 29.24, a P/E/G ratio of 2.07 and a beta of 1.03. Danaher Co. has a 52-week low of $78.97 and a 52-week high of $98.88. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00.
Danaher (NYSE:DHR) last released its earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The firm had revenue of $4.53 billion during the quarter, compared to analyst estimates of $4.47 billion. Danaher had a return on equity of 11.29% and a net margin of 13.36%. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.87 earnings per share. equities research analysts forecast that Danaher Co. will post 3.99 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a dividend of $0.14 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $0.56 annualized dividend and a yield of 0.57%. Danaher’s dividend payout ratio is presently 16.67%.
In other Danaher news, Director Donald J. Ehrlich sold 10,578 shares of the company’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total transaction of $960,693.96. Following the completion of the sale, the director now directly owns 104,621 shares in the company, valued at $9,501,679.22. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Daniel L. Comas sold 88,184 shares of the company’s stock in a transaction dated Monday, October 23rd. The stock was sold at an average price of $91.02, for a total value of $8,026,507.68. Following the sale, the chief financial officer now owns 227,816 shares of the company’s stock, valued at $20,735,812.32. The disclosure for this sale can be found here. Insiders have sold 273,810 shares of company stock valued at $25,218,813 over the last 90 days. 12.20% of the stock is currently owned by insiders.
TRADEMARK VIOLATION WARNING: This report was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/01/11/national-investment-services-inc-wi-has-2-80-million-stake-in-danaher-co-dhr.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.